Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 61 AL 75

Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment

Jang YJ, Kang SJ, Park HS, Lee DH, Kim JH, Kim JE, Kim DI, Chung CH, Yoon JK, Bhang SH.

J Nanobiotechnology. 2025 Feb 10;23(1):99. doi: 10.1186/s12951-025-03109-3.

FKBP51 functions in the regulation of circadian rhythm and Alzheimer's disease

Johnson JL.

Cell Stress Chaperones. 2025 Mar;30(2):81-83. doi: 10.1016/j.cstres.2025.02.002. Epub 2025 Feb 9.

Neurobiological role and therapeutic potential of exercise-induced irisin in Alzheimer's disease management

Ratne N, Jari S, Tadas M, Katariya R, Kale M, Kotagale N, Madia D, Umekar M, Taksande B.

Ageing Res Rev. 2025 Mar;105:102687. doi: 10.1016/j.arr.2025.102687. Epub 2025 Feb 10.

1,3,5-Triazine: A Promising Molecular Scaffold for Novel Agents for the Treatment of Alzheimer's Disease

Silva CFM, Guerrinha APDMS, Carvalho S, Pinto DCGA, Silva AMS.

Int J Mol Sci. 2025 Jan 21;26(3):882. doi: 10.3390/ijms26030882.

Deciphering the Functions of Raphe-Hippocampal Serotonergic and Glutamatergic Circuits and Their Deficits in Alzheimer's Disease

Yu W, Zhang R, Zhang A, Mei Y.

Int J Mol Sci. 2025 Jan 30;26(3):1234. doi: 10.3390/ijms26031234.

Safety concerns associated with BACE1 inhibitors - past, present, and future

Naidu A, Silverglate B, Silverglate M, Grossberg GT.

Expert Opin Drug Saf. 2025 Jul;24(7):767-772. doi: 10.1080/14740338.2025.2467811. Epub 2025 Feb 23.

Bridging gap in the treatment of Alzheimer's disease via postbiotics: Current practices and future prospects

Bashir B, Gulati M, Vishwas S, Gupta G, Dhanasekaran M, Paudel KR, Chellappan DK, Anand K, Negi P, Singh PK, Rajput A, Dua K, Singh SK.

Ageing Res Rev. 2025 Mar;105:102689. doi: 10.1016/j.arr.2025.102689. Epub 2025 Feb 12.

Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease

Streit WJ, Phan L, Bechmann I.

Pharmacol Rev. 2025 Jan;77(1):100005. doi: 10.1124/pharmrev.123.000823. Epub 2024 Nov 22.

Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics

Xavier C, Pinto N.

J Alzheimers Dis. 2025 Apr;104(3):611-626. doi: 10.1177/13872877251317543. Epub 2025 Feb 16.

Poetry interventions in Alzheimer's and dementia care: A scoping review

Paniagua Guzman A, Otto AK, Galeeva I, Brown SJ, Jacklin K.

Dementia (London). 2025 Oct;24(7):1314-1333. doi: 10.1177/14713012251321022. Epub 2025 Feb 17.

Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer's disease pathogenesis

Kalra P, Grewal AK, Khan H, Singh TG.

Neuroscience. 2025 Apr 6;571:74-88. doi: 10.1016/j.neuroscience.2025.02.037. Epub 2025 Feb 17.

Drug repurposing for Alzheimer's disease and other neurodegenerative disorders

Cummings JL, Zhou Y, Van Stone A, Cammann D, Tonegawa-Kuji R, Fonseca J, Cheng F.

Nat Commun. 2025 Feb 19;16(1):1755. doi: 10.1038/s41467-025-56690-4.

Tg-SwDI transgenic mice: A suitable model for Alzheimer's disease and cerebral amyloid angiopathy basic research and preclinical studies

Rodriguez-Lopez A, Esteban D, Domínguez-Romero AN, Gevorkian G.

Exp Neurol. 2025 May;387:115189. doi: 10.1016/j.expneurol.2025.115189. Epub 2025 Feb 18.

Hericium erinaceus: A possible future therapeutic treatment for the prevention and delayed progression of Alzheimer's disease? - A narrative review

Cornford N, Charnley M.

Nutr Res Rev. 2025 Dec;38(2):613-627. doi: 10.1017/S0954422425000058. Epub 2025 Feb 24.

SARS-CoV-2: A synergy to the Alzheimer's disease

Shaik KM, Kumar D, Srikanth P, Nandi S.

J Neurovirol. 2025 Feb;31(1):16-23. doi: 10.1007/s13365-025-01247-w. Epub 2025 Feb 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias